Introduction
Vitamin D 3 must be metabolized twice to function as a key regulator of mineral ion homeostasis. In the liver, it is hydroxylated at carbon 25, and in the kidney, it is hydroxylated at position 1 to produce 1,25(OH) 2 D 3 , the hormonal form of vitamin D 3 (1) . Upon reaching its target tissues, 1,25(OH) 2 D 3 binds to its specific receptor, the vitamin D receptor (VDR), to regulate the transcription of vitamin D 3 target genes responsible for carrying out the physiological actions of 1,25(OH) 2 D 3 : mineral homeostasis, skeletal homeostasis, and cellular differentiation (2) . Among several target genes, the 1,25(OH) 2 CYP24A1 catalyzes the addition of a hydroxyl group on carbon 24 of 1,25(OH) 2 D 3 (4) . This initiates the 24-oxidation pathway leading to 1,25(OH) 2 D 3 catabolism (3). The 25(OH)D 3 metabolite also serves as a substrate for the CYP24A1 enzyme, leading to the production of 24R,25(OH) 2 D 3 (4, 5) . The bioactivity of 24R,25(OH) 2 D 3 remains controversial. It has been proposed that it might contribute to fracture repair (6) (7) (8) , but limited information is available on this putative function of the metabolite. Indirect (secondary) bone healing is the most common fracture repair mechanism, since it does not require rigidly stable conditions (9) . This process begins with an acute inflammatory response at the fracture site, where immune and precursor cells are recruited. The fracture gap is then bridged by fibrocartilaginous callus tissue subsequently mineralized through endochondral and intramembranous ossification. Finally, the mineralized callus is progressively remodeled into lamellar bone (9) .
The idea that 24R,25(OH) 2 D 3 contributes to bone healing stems from the observation that its circulating levels increase during fracture repair in chickens as a result of an increase in CYP24A1 activity (8) . When the effect of various vitamin D 3 metabolites on the mechanical properties of healed bones was tested, treatment with 24R,25(OH) 2 D 3 was necessary to achieve optimal healing (6) . These results indicate that 24R,25(OH) 2 D 3 plays an essential role as a vitamin D metabolite important for fracture repair. The mechanism of action has remained elusive, although studies have suggested the presence of a binding activity for 24R,25(OH) 2 D 3 in membrane fractions from chicken tibial fracture-healing callus (7, 10) .
We took advantage of the previously generated Cyp24a1-null mice (11) to examine the putative role of 24R,25(OH) 2 D 3 and its mechanism of action in mammalian fracture repair. We have measured a significant, reproducible impairment in callus formation during fracture repair in Cyp24a1-null mice. The callus formation defect was corrected by exogenous administration of 24R,25(OH) 2 Figure 1D , lower detection limit of the assay), and circulating 25(OH)D 3 was elevated (Figure 1E ). Neither Cyp24a1 deletion nor exogenous 24R,25(OH) 2 D 3 injections in control or Cyp24a1-null mice had any effect on basal bone constitution, as tibia length ( Figure 1F ), trabecular structure (volume, number, and thickness) (Figures 1, G-I), and tibia stiffness ( Figure 1J) were not altered. A bone fracture-healing time course in 12-week-old Cyp24a1-null mice revealed a significant, reproducible reduction in callus volume compared with that of control littermates on post-osteotomy days 14 and 18, which caught up at later time points ( Figure 1K ). This impairment in callus formation was observed whether the osteotomized bone was immobilized via intramedullary rodding ( Figure 1K ) or with an external fixator ( Figure 1M , vehicle). All further experiments therefore took place on day 14 or day 18. Since local production of 24R,25(OH) 2 D 3 was reported in chicken callus, we monitored Cyp24a1 expression in callus tissue of control and null mice. We detected Cyp24a1 expression in control callus tissue starting on day 14 ( Figure 1L ). Systemic injection of 24R,25(OH) 2 D 3 decreased Cyp24a1 expression ( Figure 1L ) and restored mineral- Table 1 and Supplemental Figures 1 and 2 ; supplemental material available online with this article; https://doi.org/10.1172/JCI98093DS1), we used them as controls. Surviving Cyp24a1-null mice were normocalcemic and normophosphatemic ( Figure 1, A and B) , with circulating levels of 1,25(OH) 2 D 3 comparable to those of controls ( Figure 1C and Supplemental Figure 1E ). Serum concentrations Figure 2C ). Basic Local Alignment Search Tool (BLAST) screening of the 150006O10 sequence against the Mus musculus genome identified Fam57b as the only match (Supplemental Figure 3A) . This gene encodes 3 protein isoforms, differing by the first 50 amino acid residues of their N-termini (Supplemental Figure 3B) . We ran an isoform-specific expression panel in various tissues and found that Fam57b1 was preferentially expressed in the brain ( Figure 2E ), while Fam57b2 was most prominent in cartilage and skin, with levels in lung somewhat higher than those in the brain ( Figure 2F ). Isoform 3 was reported to be preferentially expressed in testis (14) and was not further investigated. Fam57b2 expression was upregulated in Cyp24a1-null lung tissue but not in skin (Supplemental Figure 4) . A time-course analysis of the expression of Fam57b isoforms in callus tissue from Cyp24a1-null mice and control littermates showed ized callus volume ( Figure 1M ) and mechanical properties ( Figure  1N ). We found that administration of 1,25(OH) 2 D 3 did not restore mineralized callus volume ( Figure 1M ).
Fam57b identification from callus tissue. Gene expression monitoring with microarrays using RNA from day 14 callus tissue of control or Cyp24a1-null mice was performed to identify potential effector molecules of the 24R,25(OH) 2 D 3 signal. We postulated that in the absence of a putative 24R,25(OH) 2 D 3 negative feedback loop, the gene encoding the effector molecule may be overexpressed in the repair callus from Cyp24a1 -/-animals. Since previous studies suggested the presence of a membrane receptor for 24R,25(OH) 2 D 3 in chicken tibial fracture callus (7, 10), we added the selection criterion of membrane-associated proteins with no annotated function (at the time the assay was performed). The microarray analysis identified 4 genes that were selectively upregulated in null tissue and met the other selection criteria: RIKEN clones 1500002O20, 2310046K23, 1500016O10, and 1110020A10 (Supplemental Table 2 ). Only clone 1500016O10 was shown to bind tritiated 24R,25(OH) 2 (C and D) Binding competition analysis. **P < 0.01 and ***P < 0.001, by 1-way ANOVA followed by Dunnett's post test; 1-site fit K i (n = 3). Pg, progesterone. (E and F) Fam57b isoform expression in tissues. Relative expression levels were determined by reverse transcription quantitative PCR (RT-qPCR) and normalized to B2m. Expression in brain (Br) was arbitrarily assigned a value of 1. LB, long bones; SI, small intestine; Cal, calvaria; Cart, cartilage; Hrt, heart; Kid, kidney; Mus, skeletal muscle. Relative expression is indicated by numerals above each bar. (G and H) Fam57b isoform expression in fracture callus. Relative expression levels were determined at intervals by RT-qPCR and normalized to B2m; expression in contralateral tibia (No OT) was arbitrarily assigned a value of 1. *P < 0.05, by 2-way ANOVA followed by Bonferroni's post test. (I-L) Expression of Fam57b isoforms following 24R,25(OH) 2 D 3 treatment in callus (I and K) or primary cultures of chondrocytes (J and L). *P < 0.05, **P < 0.01, and ***P < 0.001, by 2-way ANOVA followed by Bonferroni's post test (n = 6). The number of animals per group is indicated in parentheses. jci. Figure 2I ) as well as in primary cultures of chondrocytes ( Figure 2J ), supporting the retroinhibition feedback mechanism postulated as a criterion for microarray target selecthat isoform 1 remained expressed at low levels and was not modulated during fracture repair ( Figure 2G ). In contrast, isoform 2 was found to be significantly upregulated on post-osteotomy day 14 in Cyp24a1-null callus tissue ( Figure 2H ). Treatment with -/-mice, with or without a 24-hour exposure to 1 μM LacCer. **P < 0.01 and ***P < 0.001, by 2-way ANOVA followed by Bonferroni's post test (n = 6). (J) Callus volume quantification was determined by micro-CT. *P < 0.05 and **P < 0.01, by 2-way ANOVA followed by Bonferroni's post test. (K) X-ray projections of callus of chondrocyte-specific Fam57b-deficient mice on day 14 and day 18 after osteotomy. fl/fl WT, control Fam57b mice; fl/fl Cre, chondrocyte-specific Fam57b-deficient mice. The number of animals per group is indicated in parentheses. jci.org
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In vivo rescue experiments. To confirm the involvement of LacCer in bone fracture repair, Cyp24a1-null and chondrocyte-specific Fam57b-deleted mice were injected subcutaneously with this lipid after osteotomy. Computer-assisted microtomography (micro-CT) analyses revealed normalization of callus volume by LacCer supplementation in both mouse strains ( Figure Monitoring of chondrogenic marker expression in callus. Our data suggest that healing was impaired during the endochondral phase of fracture repair in Cyp24a1-null and chondrocyte-specific Fam57b-deleted mice. We thus monitored the expression of markers of cartilage maturation in calluses from control and mutant littermates during the rescue treatment. Of the genes assessed, collagen type II α 1 chain (Col2a1) and aggrecan (Acan) were both upregulated by either 24R,25(OH) 2 (19) . Another aspect of bone biology in which investigators have sought to identify a role for tion. We found that supplementation with 24R,25(OH) 2 D 3 had no impact on the relative expression levels of Fam57b1 in either genotype, whether in vivo ( Figure 2K ) or in vitro ( Figure 2L) .
In vitro characterization of FAM57B2 protein. In addition to transmembrane motifs, FAM57B2 contains a domain related to acyl-CoA-dependent ceramide synthase, and overexpression of FAM57B2 was reported to increase ceramide production in adipocytes (14) . We adapted this assay to challenge FAM57B2 (from transfected HEK293 cells) with vitamin D 3 metabolites to determine whether 24R,25(OH) 2 D 3 binding could modulate FAM57B2 enzymatic activity. Because this protocol requires the presence of BSA, which reduces metabolite availability, we increased the effective dose of 24R,25(OH) 2 D 3 to 1 μM, despite the nM-range K D . Moreover, the substrate and cofactor concentrations are set in the μM range for the assay (14) . Cells were grown in vitamin D 3 -depleted serum for the preparation of lysates used in the enzyme assay. We observed 24R,25(OH) 2 Figure 3A , lane 12). The allosteric modulation of FAM57B2 enzymatic activity was specific to the natural epimer of the 24-hydroxylated metabolite 24R,25(OH) 2 Figure 3A , lanes 9-11 and lane 13, respectively). Cell lysates from vector-transfected cells did not produce LacCer ( Figure 3A , lanes 1-6), and we detected no contaminants in the reaction buffers ( Figure 3B) .
Involvement of FAM57B2 in fracture repair in vivo.
We generated a mouse strain in which the Fam57b gene can be specifically inactivated in selected tissues. Removal of the floxed exon 6 introduced a frameshift and produced a null allele (Supplemental Figure 5A) . We bred Fam57b-floxed mice with Col2-Cre-transgenic mice (17) to achieve chondrocyte-specific gene inactivation (Supplemental Figure 5B ). This was confirmed by immunofluorescence staining of growth plate sections from Col2-Cre Fam57b fl/fl mice with an anti-FAM57B antibody (Supplemental Figure 5C ). Since Fam57b2 is the main isoform expressed in chondrocytes ( Figure 2 , E and F), this strategy allowed for evaluation of the putative role of FAM57B2 in endochondral ossification during fracture repair. First, we verified that tibia length ( Figure 3C ), trabecular structure (volume, number, and thickness) (Figure 3 , D-F), and tibia stiffness ( Figure  3G ) remained unaffected by the chondrocyte-specific gene deletion under basal conditions. The fact that Fam57b2 expression was normalized by LacCer treatment in Cyp24a1 -/-callus tissue ( Figure  3H ) and primary chondrocytes ( Figure 3I ) suggests some type of feedback mechanism. If FAM57B2 is a physiological effector of the 24R,25(OH) 2 D 3 signal, the model predicts that chondrocyte-specific inactivation of Fam57b will replicate the impaired callus formation phenotype of Cyp24a1-null mice that cannot generate the 24R,25(OH) 2 24R,25(OH) 2 D 3 is fracture repair (6) (7) (8) . Field observation data suggest that in the wild, long bone fractures in adults are rare and commonly fatal (20) . Selection pressure to evolve an improved healing mechanism when the injury is uncommon and universally fatal is by definition slight (21) . This may explain why multiple pathways act in parallel or redundantly to restore structure and function to broken bone tissue (22) . The results reported herein characterize one such pathway. We have used Cyp24a1-null mice (11) to study fracture repair in a 24R,25(OH) 2 D 3 -depleted mammalian system. These mice displayed suboptimal repair during the endochondral ossification phase. This interpretation is supported by the time point at which we measured a significant difference in callus volume (day 14 and day 18), which coincides with the time range of Cyp24a1 expression in this tissue. In addition, previous results from our group show that distraction osteogenesis, whereby bone regeneration occurs predominantly through intramembranous bone formation (23), is not affected by Cyp24a1 inactivation (24) .
Comparing callus tissue gene expression between control and mutant animals allowed the cloning of Fam57b and the characterization of the chondrocyte-enriched FAM57B2 isoform. We present evidence of a genetic pathway involving 24R,25(OH) 2 D 3 -induced, FAM57B2-dependent LacCer production to optimize endochondral ossification during fracture repair. Our results argue against a VDR-mediated mechanism, since the circulating levels of 1,25(OH) 2 D 3 were normal in the surviving Cyp24a1-null animals ( Figure 1C and Supplemental Figure 1E) Figure 3A) . A VDR-independent mechanism for 24R,25(OH) 2 D 3 in fracture healing is in agreement with the hypothesis originally proposed by Seo and Norman (8) .
Human data on the role of 24R,25(OH) 2 D 3 in bone healing are scarce. Available studies are limited to the measurement of circulating levels of vitamin D 3 metabolites at different intervals following fracture. The results are conflicting, with increases in serum 24R,25(OH) 2 D 3 reported in young patients (25) , while no changes were detected in older cohorts (26, 27) . Though CYP24A1 polymorphisms have been associated with human syndromes, the fracture risk does not seem to be increased, and it remains unknown whether any alteration in the fracture repair process occurs as a result of these polymorphisms. It would be informative to monitor bone healing following fracture as well as FAM57B isoform expression in patients with idiopathic infantile hypercalcemia (IIH) and Lightwood syndrome, which are caused by mutations in the CYP24A1 gene (28-30) . repair phase seems to be affected by Cyp24a1 or Fam57b deletion, FAM57B2 might link vitamin D 3 metabolism to sphingolipid production to modulate Col2a1 and Acan expression. Increasing evidence highlights the role of sphingolipids in cartilage homeostasis (45, 46) . Indeed, sphingolipids have been shown to influence Col2a1 expression (47) as well as chondrocyte apoptosis and matrix turnover (48) . The Ugcg gene encodes the enzyme that produces glucosylceramide (GluCer), which is the conventional precursor to LacCer. Chondrocyte-specific deletion of Ugcg showed that glycosphingolipids help to preserve cartilage integrity during experimental OA (49) . The parallel between the OA models of Boyan (44) and Seito (49) indicates a correlation between 24R,25(OH) 2 D 3 and glycosphingolipid production in cartilage homeostasis. Gangliosides, i.e., sialylated glycosphingolipids, are produced from LacCer (36) and are abundant in cartilage matrix (46) . Gangliosides show a dual role in cartilage homeostasis, as their depletion can enhance cartilage repair by preventing chondrocyte hypertrophy (50) or accelerate its degradation during experimental OA (37) .
Interestingly, a fracture repair study by Momma and colleagues (51) performed in Col2-Cre Ugcg-floxed mice showed a more severe phenotype than that described here. We hypothesize that Cyp24a1-null and Col2-Cre Fam57b fl/fl mice only partially phenocopy the Col2-Cre Ugcg fl/fl mouse, because GluCer synthesis remains unaffected. Moreover, since global glycosphingolipid metabolism remains intact in Col2-Cre Fam57b-floxed mice, our results suggest that LacCer production through the 24R,25(OH) 2 D 3 /FAM57B2 pathway might represent a local mechanism solicited in stress-related contexts such as healing and OA. These 2 pathways are probably redundant mechanisms that act to maximize the outcome of bone healing. LacCer synthesis classically occurs through galactosyl transfer onto a GluCer substrate (36) . However, FAM57B2 has very little sequence homology with characterized LacCer synthases and further requires sphingosine (and not GluCer) as a substrate to produce LacCer following 24R,25(OH) 2 D 3 binding. We surmise that GluCer treatment could ameliorate fracture repair but that this would occur through FAM57B2-independent mechanisms.
Few data exist concerning the function of FAM57B2. In adipocytes, Fam57b was identified as a transcriptional target of PPARγ, a member of the nuclear receptor family of transcription factors. The authors have shown that FAM57B2 inhibits adipogenesis (14) . This is particularly interesting in the context of recent results showing that high callus adiposity is associated with delayed fracture healing and weakened biomechanical properties (52) . Thus, inhibition of adipogenesis by FAM57B2 could play a beneficial role during fracture repair. The high constitutive expression of Fam57b2 in skin (Supplemental Figure 4B) hints at the possibility that FAM57B2 might also play a role in keratinocyte differentiation or skin wound repair. In humans, the FAM57B gene was found to be expressed at higher levels in individuals who heal normally when compared with those suffering non-union fractures (Gene Expression Omnibus [GEO] GDS369, accessible at www.ncbi.nlm.nih. gov/sites/GDSbrowser?acc=GDS369), indicating a role in fracture repair. Though both isoforms 1 and 2 are associated with ceramide production in vitro (14) , allosteric modulation toward LacCer synthesis by 24R,25(OH) 2 D 3 appears to be specific to isoform 2. An The 24R,25(OH) 2 D 3 -induced production of LacCer by FAM57B2 shows features of allosteric enzymatic regulation, a well-established model for multimeric enzymes (31) that has also been demonstrated for monomeric enzymes (32) . In allosteric enzyme regulation, the allosteric ligand binds in a specific, saturable manner at a site separate from the enzymatic active site, modifying the protein's conformation to modulate its activity (33) . The allosteric modulator can regulate both the activity level and substrate specificity of the enzyme (31 (13) . However, structure-function analysis of the FAM57B2 protein remains to be performed to identify key residues for the enzymatic activity and to define the 24R,25(OH) 2 D 3 binding pocket.
The 24R,25(OH) 2 D 3 molecule is a circulating vitamin D 3 metabolite, and it remains unclear whether it needs to be synthesized at the fracture site to exert beneficial effects, or whether 24R,25(OH) 2 D 3 from the circulation is sufficient. Given that chondrocytes are compartmentalized prior to vascularization of the repair callus, local synthesis of 24R,25(OH) 2 D 3 may contribute significantly to the healing process. The question was not answered by our experiments, since the targeted mutation of the Cyp24a1 allele that we generated led to global inactivation of the gene (11) . Our data, however, indirectly indicate a contribution of local synthesis, since Cyp24a1 expression was stimulated in callus tissue within the appropriate time range. The rescue treatment we used led to high circulating levels of 24R,25(OH) 2 D 3 (Supplemental Figure 7B) , which may have been necessary to allow access of the metabolite to the target cell in the hypovascularized callus. Considering that FAM57B2 is coexpressed in chondrocytes, we favor a model in which 24R,25(OH) 2 D 3 acts via an intracrine (34) mechanism through endogenous synthesis in chondrocytes. Another potential source could be neighboring osteoblasts in paracrine signaling. Alternatively, injury macrophages, recently shown to be indispensable for efficient fracture repair (35) , could represent a physiologically relevant source of the 24R,25(OH) 2 D 3 metabolite. A floxed Cyp24a1 allele and cell typespecific Cre drivers will be required to clarify this point. These experiments are in progress in our laboratory.
LacCer is the most important and abundant of the diosylceramides. It serves as the metabolic branch point for the formation of the different classes of complex glycosphingolipids in mammals (36, 37) . In addition to its pivotal role in the biosynthesis of nearly all major glycosphingolipids, LacCer is also thought to regulate several aspects of cellular function (36) . Specific signal transduction pathways involving LacCer have been characterized (36) . These pathways have been shown to affect cell proliferation (38) , adhesion (39, 40) , apoptosis (41) , and angiogenesis (42) . Little is known about a specific role for LacCer in bone (43) . We have initiated experiments to determine whether LacCer can modulate the proliferation, differentiation, or survival of chondrocytes.
Recent work from Boyan and colleagues (44) ethyl acetate for 30 minutes at room temperature in the dark and then a second time for 60 minutes. The reaction was stopped by addition of ethanol, and the samples were dried and redissolved in 60:40 methanol/water running buffer. LC-MS/MS analysis was performed using an Acquity UPLC connected in-line with a Xevo TQ-S mass spectrometer in electrospray-positive mode (Waters Corporation). Through a Queen's University and Waters Corporation agreement, Waters provided the LC-MS/MS instrument used in this study. Chromatographic separations were achieved using a BEH-phenyl ultra-performance LC (UPLC) column (1.7 μm, 2.1 × 50 mm) (Waters) and a methanol-waterbased gradient solvent system. Micro-CT. Calluses and contralateral tibiae were harvested in PBS, scanned with a model 1272 SkyScan micro-CT system (Bruker) at 65 kV, 142 μAmp, 5-μm resolution, and a 0.5° rotation using a 0.5-mm aluminum filter, and frozen at -20°C until 3-point bending tests (3PBTs). Raw data sets were reconstructed with InstaRecon software (Bruker) and analyzed with CTAn software (Bruker). Volumes of interest consisted of 400 slices (2-mm-thick) above and below the osteotomy site and used to obtain the mineralized callus volume , and control littermate mice were preoperatively injected with buprenorphine (0.1 mg/kg; Chiron Compounding Pharmacy) and underwent isoflurane general anesthesia. Skin was incised above the left knee, and the patellar ligament was detached from the lateral tissue on both sides. The tibial plateau was perforated under the ligament with a 26-gauge needle (Terumo), and a 25-gauge internal spinal wire guide (BD) was inserted down the medullary canal. The needle was pulled out, and the wire guide was bent 90° and cut at the tibial plateau, and then secured under the ligament with stitching (5-0; Ethicon). The tibial mid-shaft was exposed, and osteotomy was performed 2-3 mm above the tibiofibular junction using scissors. A drop of a 1:1 mix of 1 % lidocaine (Zoetis) and 1 % bupivicaine (Hospira) was topically applied, and the skin was sutured. Mice were injected with 0.05 mg/kg carprofen (Zoetis) at the time of surgery and postoperatively if they exhibited signs of pain during the next 48-hour period. Animals were sacrificed at intervals (10, 14, 18, 21, or 28 days) after surgery (indicated in the figures). For euthanasia, the mice were given a lethal injection of a ketamine (Vetoquinol), xylazine (Bayer), and acepromazine (Boehringer Ingelheim) cocktail before exsanguination, followed by cervical dislocation prior to dissection. Calluses and contralateral tibiae were harvested for analysis.
Osteotomy with external fixator. The surgical procedure for installation of the miniature distraction osteogenesis apparatus designed by Tay et al. (56) has been described previously (57) . The apparatus was used without distraction as an external static fixator for osteotomy healing on 12-week-old mice.
Rescue treatment with 24R,25(OH) 2 
Methods
Animals and feeding. Mice were housed under a 12-hour light/12-hour dark cycle and maintained at 25°C with free access to food and water. The Cyp24a1-null mouse strain has been described previously (11) and was maintained on a mixed genetic background (129Sv/C57BL6) for 69 generations. To maximize the number of test animals available for the study, breeding pairs consisted of homozygous mutant males (Cyp24a1 Table 1) between Cyp24a1
, and Cyp24a1 -/-littermates.
The Fam57b-targeted allele is based on the International Knockout Mouse Consortium's knockout first reporter-tagged insertion promotor-driven cassette (53) and targets exon 6 within Fam57b, producing a null allele. Embryonic stem (ES) cells carrying the floxed allele were purchased from the European Conditional Mouse Mutagenesis Program (EUCOMM) (Neuherberg, Germany) and injected into C57BL6 blastocysts at the core facility of the Centre Hospitalier de l'Université de Montréal. Chimeric males were bred with C57BL6 females, and germline transmission was confirmed by PCR analysis from tail-snip DNA (54) . Heterozygotes for the floxed allele were interbred to produce animals of all 3 possible genotypes (+/+, +/fl, and fl/ fl). Subsequent breeding involved the Col2-Cre-transgenic mouse strain (17) Figure 4 and data not shown). Serum biochemistry. Total serum calcium and serum phosphate levels were measured using an automated analyzer. Serum levels of vitamin D metabolites were assayed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) following DMEQ-TAD derivatization as described previously (55) . Briefly, serum aliquots and calibrators were diluted 1:3 with water and spiked with internal standards. Proteins were precipitated by sequentially adding 0.1 M HCl, 0.2 M zinc sulfate, and 40 μl methanol, with vortexing after the addition of each component. Tubes were centrifuged for 10 minutes at 12,000 g, and supernatants were transferred to borosilicate glass tubes. Organic extraction was carried out by adding equal volumes of hexane and methyl tertiary butyl ether with vortexing after the addition of each component. The upper organic phase was transferred into LC-MS/ MS sample vials and evaporated under nitrogen flow. Dried residues were derivatized by addition of 0.1 mg/ml DMEQ-TAD dissolved in jci.org Volume 128 Number 8 August 2018
Binding assays. Membrane fractions were prepared as described by Patino and Thomas (59) . Briefly, transfected COS7 cells were harvested in ice-cold HAED buffer (25 mM HEPES, pH 7.6, 10 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA) containing protease inhibitors, sonicated with 3 short bursts, and sequentially centrifuged for 7 minutes at 1,000 g and then for 20 minutes at 20,000 g. The resulting pellets were solubilized in HAED buffer to 1 mg/ml and kept on ice until use in the binding assays. Membrane fractions (200-400 μg in 250 μl) were incubated in a range of (57) .
Overexpression of FAM57B2. The coding sequence for murine Fam57b2 was inserted into the pcDNA3.1 plasmid (Invitrogen, Thermo Fisher Scientific) and transfected into HEK293 cells (ATCC) using lipofectamine, in parallel with an empty construct, using 5 μg DNA per 100-mm dish of 50% confluent cells in 5 ml FBS-free DMEM. Cells were incubated for 2 hours at Lipid extraction and thin-layer chromatography. Lipids were extracted by Folch's partition method (60) . Briefly, samples were mixed with chloroform/methanol/water in a 2:1:0.8 ratio, with vortexing between the addition of each component. Samples were vortexed at maximum speed for 10 seconds, and phase separation was completed with centrifugation (2,000 g, 1 min). Aqueous phases were discarded, and organic phases were evaporated under N2(g). The remaining film was dissolved in 30 μl of methanol/chloroform (1:1) and loaded onto thin-layer chromatography (TLC) plates that were developed using (50:42:10) chloroform/methanol/0.2% CaCl 2 (aq) as a mobile phase. Lipids were and to avoid hypervitaminosis and hypercalcemia in 1,25(OH) 2 D 3 -treated Cyp24a1-null mice (11) . The levels of 24R,25(OH) 2 D 3 were measured by LC-MS/MS following rescue treatment and found to be 4-fold higher in the treated Cyp24a1 -/-mice as compared with the treated controls (197 ± 31 ng/ml vs. 827 ± 147 ng/ml; P < 0.001, control vs. mutant; n = 6, respectively) (Supplemental Figure 7B ). This treatment also significantly decreased 1,25(OH) 2 D 3 and increased 1,24,25(OH) 3 D 3 in both genotypes (Supplemental Figure 7 , C and D).
Rescue with LacCer used C18-LacCer at 50 μg/kg daily in 50 μl propylene glycol with trace DMSO for solubility or the propylene glycol with trace DMSO vehicle until sacrifice. LacCer injections had no detectable impact on any of the circulating vitamin D 3 metabolites levels measured (Supplemental Figure 7) .
Gene expression monitoring. Calluses were harvested at specified time points (see figure legends), collected in RNAlater (Invitrogen, Thermo Fisher Scientific) and used for total RNA extraction in QIAzol (QIAGEN). Resuspended RNA was cleansed using the QIAGEN RNA Protect Kit, and 260:280 and 260:230 ratios were evaluated with NanoDrop (Thermo Fisher Scientific). RNA samples with a 260:280 ratio above 1.9 and 260:230 ratios above 2 were reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems), and gene expression was assessed in a QuantStudio 7 Flex apparatus (Applied Biosystems) using Taqman-specific probes for β-microglobulin (B2m), Acan, Col2a1, Col10a1, Mgp, Comp, and Hapnl1, as well as Cyp24a1, Fam57b1, and Fam57b2 (Applied Biosystems).
3PBTs. For the 3PBTs, contralateral and callus tibiae were thawed overnight at room temperature and tested for mechanical properties using an Instron model 5943 single-column table frame machine. A load-sensing cell was applied on the widest part of the callus, or 2 to 3 mm above the tibiofibular junction in the case of intact tibiae, which were held by holders set 6 mm apart. The raw output used for comparison was stiffness (N/mm).
Gene expression monitoring using microarrays. RNA samples from day 14 calluses from control and Cyp24a1-null mice were sent to the Genome Quebec and McGill University Innovation Centre (Montreal, Quebec, Canada) for microarray analysis. Briefly, RNA quality was assessed as described above, and first-and second-strand cDNAs were synthesized, followed by complementary RNA (cRNA) amplification and purification. Second-cycle single-stranded cDNA was synthesized and purified and then fragmented and biotinylated. Labeled cDNA was then hybridized on a GeneChip MOE430 2.0 (Affymetrix, Applied Biosystems). The resulting data allowed the identification of 4 genes using the following criteria: (a) selective overexpression in Cyp24a1-null tissue; (b) sequences coding for membrane-associated proteins; and/or (c) sequences coding for proteins of unknown function (Supplemental Table 2 ; the complete data set has been deposited in the Gene Expression Omnibus repository under the accession number GEO GSE112449).
Cloning and expression of candidate genes. Full-length cDNAs corresponding to the genes identified by microarrays (GenBank accession numbers AK005271, AK005126, AK003840, and AK009853) were obtained from the RIKEN Cell Bank and cloned inside a modified pBluescript SK plasmid (Stratagene) using competent bacteria, and then subcloned into the pcDNA3. Statistics. Binding and statistical analyses were performed with GraphPad Prism 5 (GraphPad Software). One-site specific binding with a Hill slope equation was used in saturation analyses to estimate K D , H, and Bmax values; a one-site fit K i equation was used in competition analyses to estimate K i values. The ROUT test in GraphPad Prism was applied to eliminate outliers from the nonlinear regression using a Q value of 0.01. Statistical analyses were performed using a 2-tailed t test or a 1-way or 2-way ANOVA, followed by Dunnett's or Bonferroni's post hoc test. Outliers were identified using the Grubbs test (extreme studentized deviate). The statistical significance threshold was set at a P value of less than 0.05. All data are presented as the mean ± SEM.
Study approval. The animal use protocol (AUP 4138) and all standard operating procedures were approved by the IACUC of Shriners Hospitals for Children -Canada, as part of the McGill University animal ethics and care program, and followed the guidelines of the Canadian Council on Animal Care.
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revealed with 10% copper sulfate in 8% phosphoric acid, followed by charring in a toaster oven set at 200°F for 5 to 10 minutes. Sphingosine (Sp), LacCer, phosphatidylcholine (PC), and phosphatidylethanolamine (PE) were loaded as standards (Avanti Polar Lipids).
Primary chondrocyte isolation. The procedure was modified from that of Mackay et al. (61) . Briefly, femoral and tibial articular cartilage from 8-week-old Cyp24a1-null mice and age-matched littermates was dissected and cleansed of soft tissue under sterile conditions, followed by a 1-hour predigestion in 1 mg/ml collagenase I from C. histolyticum (MilliporeSigma) at 37°C to eliminate the remaining soft tissue. Cartilage was then cut into small pieces and sequentially digested in 200 μg/ml collagenase I in DMEM 3 times for 24 hours with vigorous agitation at 37°C. Between each digestion, supernatants were harvested and strained (80-μm) before plating in DMEM supplemented with 10% FBS. Adherent cells were thoroughly washed with PBS and expanded.
Treatment of chondrocytes with LacCer or 24R,25(OH) 2 D 3 . Chondrocytes were plated in 12-well plates, and at confluence, the medium was changed for DMEM, without FBS, supplemented with 1 μM LacCer, 100 nM 24R,25(OH) 2 D 3 , or vehicle for 24 hours. The cells were rinsed twice with PBS, and RNA was extracted using QIAzol reagent according to the manufacturer's protocol. RNA was reverse transcribed, and Fam57b2 expression was monitored using specific probes (Applied Biosystems) and normalized to B2m.
Histology. Bones were fixed in 70% ethanol with 1% glycerol and kept at -20°C until processing. Bones were dehydrated at 4°C and infiltrated with low-temperature polymerizing methylmethacrylate (MMA) solutions 1, 2, and 3 as described by Erben (62) . Bones were embedded in MMA solution 3 supplemented with 0.4% 4-N,N,N,N-trimethylaniline (MilliporeSigma) and left to polymerize at -20 o C for 3 days under N 2 (g) atmosphere. Blocks were sectioned at 5-μm thickness using a rotary microtome equipped with a tungsten blade (Leica), stretched onto poly-L-lysine-coated superfrost slides, stacked with plastic clamps, and left to dry overnight at room temperature. For staining, sections were deplastified in xylene (1 h), ethylene glycol monoethyl ether acetate (EGMA) (1 h), and acetone (10 min) and then rehydrated with water and stained with Alcian blue H&E Y-orange G trichrome. Images were taken using a Leica DMR microscope (Leica Microsystems) connected to a digital DP70 camera (Olympus), and analyses were performed using ImageJ software (NIH).
